Literature DB >> 12167586

Mechanisms of secondary hyperparathyroidism.

Justin Silver1, Rachel Kilav, Tally Naveh-Many.   

Abstract

Small decreases in serum Ca(2+) and more prolonged increases in serum phosphate (P(i)) stimulate the parathyroid (PT) to secrete parathyroid hormone (PTH), and 1,25(OH)(2)D(3) decreases PTH synthesis and secretion. A prolonged decrease in serum Ca(2+) and 1,25(OH)(2)D(3), or increase in serum P(i), such as in patients with chronic renal failure, leads to the appropriate secondary increase in serum PTH. This secondary hyperparathyroidism involves increases in PTH gene expression, synthesis, and secretion, and if chronic, to proliferation of the PT cells. Low serum Ca(2+) leads to an increase in PTH secretion, PTH mRNA stability, and PT cell proliferation. P(i) also regulates the PT in a similar manner. The effect of Ca(2+) on the PT is mediated by a membrane Ca(2+) receptor. 1,25(OH)(2)D(3) decreases PTH gene transcription. Ca(2+) and P(i) regulate the PTH gene posttranscriptionally by regulating the binding of PT cytosolic proteins, trans factors, to a defined cis sequence in the PTH mRNA 3'-untranslated region, thereby determining the stability of the transcript. PT trans factors and cis elements have been defined.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12167586     DOI: 10.1152/ajprenal.00061.2002

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  25 in total

Review 1.  The emergence of phosphate as a specific signaling molecule in bone and other cell types in mammals.

Authors:  Solmaz Khoshniat; Annabelle Bourgine; Marion Julien; Pierre Weiss; Jérôme Guicheux; Laurent Beck
Journal:  Cell Mol Life Sci       Date:  2010-09-17       Impact factor: 9.261

2.  Sustained activation of renal N-methyl-D-aspartate receptors decreases vitamin D synthesis: a possible role for glutamate on the onset of secondary HPT.

Authors:  Eva Parisi; Milica Bozic; Mercé Ibarz; Sara Panizo; Petya Valcheva; Blai Coll; Elvira Fernández; José M Valdivielso
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-09-07       Impact factor: 4.310

Review 3.  New therapies: calcimimetics, phosphate binders and vitamin D receptor activators.

Authors:  Jorge B Cannata-Andía; Minerva Rodriguez-García; Pablo Román-García; Diego Tuñón-le Poultel; Francisco López-Hernández; Diego Rodríguez-Puyol
Journal:  Pediatr Nephrol       Date:  2010-02-12       Impact factor: 3.714

Review 4.  FGF23: its role in renal bone disease.

Authors:  Masafumi Fukagawa; Junichiro James Kazama
Journal:  Pediatr Nephrol       Date:  2006-08-24       Impact factor: 3.714

5.  Association between vitamin D receptor FokI. Polymorphism and serum parathyroid hormone level in patients with chronic renal failure.

Authors:  E Vigo Gago; C Cadarso-Suárez; R Perez-Fernandez; R Romero Burgos; J Devesa Mugica; C Segura Iglesias
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

6.  Association between abnormal thalamic metabolites and sleep disturbance in patients with end-stage renal disease.

Authors:  Xueying Ma; Yan Zhang; Shaohui Ma; Peng Li; Dun Ding; Hua Liu; Jixin Liu; Ming Zhang
Journal:  Metab Brain Dis       Date:  2018-07-04       Impact factor: 3.584

7.  Cyclooxygenase 2 promotes parathyroid hyperplasia in ESRD.

Authors:  Qian Zhang; Junsi Qiu; Haiming Li; Yanwen Lu; Xiaoyun Wang; Junwei Yang; Shaoqing Wang; Liyin Zhang; Yong Gu; Chuan-Ming Hao; Jing Chen
Journal:  J Am Soc Nephrol       Date:  2011-02-18       Impact factor: 10.121

8.  The parathyroid is a target organ for FGF23 in rats.

Authors:  Iddo Z Ben-Dov; Hillel Galitzer; Vardit Lavi-Moshayoff; Regina Goetz; Makoto Kuro-o; Moosa Mohammadi; Roy Sirkis; Tally Naveh-Many; Justin Silver
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

Review 9.  FGF-23 and secondary hyperparathyroidism in chronic kidney disease.

Authors:  Justin Silver; Tally Naveh-Many
Journal:  Nat Rev Nephrol       Date:  2013-07-23       Impact factor: 28.314

Review 10.  The enigma of hyperparathyroidism in hypophosphatemic rickets.

Authors:  Claus Peter Schmitt; Otto Mehls
Journal:  Pediatr Nephrol       Date:  2004-03-11       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.